Response and mechanisms of resistance to larotrectinib and selitrectinib in metastatic undifferentiated sarcoma harboring oncogenic fusion of NTRK1
Publication information:
Hemming M, Nathenson M, Lin J-R, Mei S, Du Z, Malik K, Marino-Enriquez A, Jagannathan J, Sorger P, Bertagnolli M. Response and mechanisms of resistance to larotrectinib and selitrectinib in metastatic undifferentiated sarcoma harboring oncogenic fusion of NTRK1. JCO precision oncology. 2020;4.